TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.

Read what InspireMD management has to say about the company's voluntary recall of its CGuard Prime 135 cm carotid stent ...

RelayPro thoracic stent grafts from Bolton Medical have failed in some cases, leading to an urgent recall. Medtronic's Mosaic ...

Cardiac infections after heart stent procedures are rare but serious, with mortality rates up to 40 percent and symptoms ...

Michael Lohan is experiencing mounting health issues ... 'cause TMZ has learned he had a major scare after undergoing a heart ...

InspireMD (Nasdaq:NSPR) announced today that, in consultation with the FDA, it recalled its CGuard Prime 135 cm carotid stent ...

U.S. revenue -- $866,000, representing 74% sequential quarter-over-quarter growth from the third quarter and attributed ...

The movie star's 66-year-old father had recently undergone an angioplasty procedure to place a stent in his heart to open up ...

Bengaluru: A small, dissolving tube developed in a Bengaluru lab is moving a step closer to hospital use, offering a way to ...

Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth ...

In a move that could directly impact the cost of heart treatment, the National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for coronary stents, effective April ...

Now, as CEO of Plymouth-based Peytant Solutions, Schorgl is leading a Twin Cities startup developing what it says is a ...